Answers are grounded in this paper and cite their sources.
Case report shows improvement of dopa-responsive dystonia in a child via deep brain stimulation, suggesting a novel treatment option.
Tyrosine hydroxylase (TH) deficiency is a rare autosomal recessive metabolic disease that results in the decreased production of catecholamines. Standard treatment relies on combinations of levodopa and carbidopa, anticholinergic agents, serotonergic agonists, and monamine oxidase B inhibitors. Unfortunately, severely affected children often require escalating doses of medication and suffer from dyskinesias as well as significant on/off symptomatology. The authors present a case of medically intractable dopa-responsive dystonia in a 6-year-old boy whose condition significantly improved with bilateral subthalamic nucleus deep brain stimulation. This case is unique in its novel approach to tyrosine hydroxylase deficiency and the young age of the patient.
No takes yet. Share an insight, caveat, or question.
Tormenti et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: